Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...
Johnson & Johnson is contributing $1 million to support the development of curricula and modernization of training and lab ...
Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, ...
President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program ...
Legit on MSN2d
Relief for SS People as Scientists Finally Discover 'Potential Cure' for Sickle Cell DiseaseNHS approves £1.65m gene therapy for sickle cell disease, offering a potential cure. A milestone for patients, especially in ...
GlobalData on MSN5d
Rentschler closes UK cell and gene therapy facility and does a pivot to biologicsCDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...
People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...
A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...
A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the ...
NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback